The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...

In this episode of The Story Behind the AP Story, we hear from Lauran Neergaard and Shelby Lum, who have been following the ...

Key Takeaways A new trial will beging testing pig livers to support people with sudden liver failureThe pig liver won't be ...

The company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...

A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a ...

Genesis, a biotechnology company developing human-compatible engineered organs to treat patients suffering from organ failure, and OrganOx Ltd., a leading organ medical technology company, today ...

A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know.

"Immediately following the transplant, it just changed his life," Mike Curtis, the president and CEO of eGenesis, told The Current host Matt Gallaway. eGenesis, based in Cambridge, Mass., ...

It’s early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions to make this approach a viable option and help ease the organ shortage ...

Seqster has attracted another pharma partner for its patient data technology, which aims to improve care through better access and understanding of patient-level real-world data (RWD). Boehringer ...